Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
about
BMI and BMD: The Potential Interplay between Obesity and Bone FragilityThe obesity of boneRisk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.Estrogens and Androgens in Skeletal Physiology and Pathophysiology.The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm.Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor αLoss of health related quality of life following low-trauma fractures in the elderlyAssessing Risk of Osteoporotic Fractures in Primary Care: Development and Validation of the FRA-HS Algorithm.Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity or Bone Mineral Density in a Randomized Trial of Overweight and Obese Postmenopausal Women.Dementia is a major risk factor for hip fractures in patients with chronic kidney disease.Evaluation of a Multi-modal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis: A Randomized Clinical Trial.A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material.Interleukin-13 Inhibits Expression of cyp27b1 in Peripheral CD14+ Cells That Is Correlated With Vertebral Bone Mineral Density of Patients With Ulcerative Colitis.Thy1 is a positive regulator of osteoblast differentiation and modulates bone homeostasis in obese mice.DEPTOR regulates osteogenic differentiation via inhibiting MEG3-mediated activation of BMP4 signaling and is involved in osteoporosis.
P2860
Q26744811-5ADBFEEE-69BE-4C53-9E08-8E765FED3954Q26775713-F552ADAF-FAE0-4C78-8CCA-3E45D979B10EQ30248491-86D2ADC2-BC18-48E5-A4DF-061B7098118EQ34543980-2984EAA7-BD7E-467B-85EC-DF61FAF1CD99Q35859866-9B9A6120-E536-456C-9CE9-C87837177D4EQ35892522-326536C5-EA05-4346-865F-DEE4734D1400Q35993966-EA4504DD-DE99-4958-9F4E-F1E0D51FDA5EQ36270538-EC3C39A9-19AA-4F73-8E6E-4E2C12AA264BQ36498024-CBF31A66-7CB7-4556-9545-6AE7CD85D5BAQ40296289-76A02C56-ADC7-4508-9144-60C38432C52FQ49609488-6A61B564-43C6-4845-B1F6-791426F8C092Q50922963-6FE36105-9D48-43F3-944B-1C25F8359BF3Q51661843-69883EE8-9C1D-423C-A0A2-64BFD9B123B4Q51755250-D1F44CE2-8EE1-4C25-A3FE-FC2AF8F0CD74Q55668617-BE8F4782-2777-46D5-913B-2CA5F4F1ED85
P2860
Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
@en
type
label
Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
@en
prefLabel
Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
@en
P2860
P356
P1476
Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
@en
P2093
GLOW investigators
Nelson B Watts
P2860
P2888
P304
P356
10.1038/NRENDO.2014.55
P577
2014-04-22T00:00:00Z